Matthew Roden

Director, iTeos Therapeutics, Inc.

Companies

Aktis Oncology, Inc.Board member Jan 8, 2026 to now¹
Aktis Oncology, Inc.Chief executive officer Jan 8, 2026 to now¹
Aktis Oncology, Inc.President Jan 8, 2026 to now¹
iTeos Therapeutics, Inc.Board member Nov 12, 2020 to Jun 10, 2022²
TURMERIC ACQUISITION CORP.Board member Oct 15, 2020 to Oct 15, 2020³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aktis Oncology, Inc. AKTS91,998 shares⁴$1.4M at $15.20Jan 8, 2026

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAktis Oncology, Inc., Board member
2
SEC EDGARiTeos Therapeutics, Inc., Board member
3
SEC EDGARTURMERIC ACQUISITION CORP., Board member
4
SEC EDGARAktis Oncology, Inc. shares after the filing of Jan 8, 2026